![Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study | Trials | Full Text Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study | Trials | Full Text](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-019-3275-x/MediaObjects/13063_2019_3275_Fig1_HTML.png)
Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study | Trials | Full Text
![IJMS | Free Full-Text | Emerging Non-Antibiotic Options Targeting Uropathogenic Mechanisms for Recurrent Uncomplicated Urinary Tract Infection IJMS | Free Full-Text | Emerging Non-Antibiotic Options Targeting Uropathogenic Mechanisms for Recurrent Uncomplicated Urinary Tract Infection](https://pub.mdpi-res.com/ijms/ijms-24-07055/article_deploy/html/images/ijms-24-07055-g001.png?1681350599)
IJMS | Free Full-Text | Emerging Non-Antibiotic Options Targeting Uropathogenic Mechanisms for Recurrent Uncomplicated Urinary Tract Infection
![PDF) A Retrospective Study of Immunotherapy Treatment with Uro-Vaxom (OM-89®) for Prophylaxis of Recurrent Urinary Tract Infections PDF) A Retrospective Study of Immunotherapy Treatment with Uro-Vaxom (OM-89®) for Prophylaxis of Recurrent Urinary Tract Infections](https://i1.rgstatic.net/publication/330360741_A_Retrospective_Study_of_Immunotherapy_Treatment_with_Uro-Vaxom_OM-89R_for_Prophylaxis_of_Recurrent_Urinary_Tract_Infections/links/5f869585458515b7cf7f6dbb/largepreview.png)
PDF) A Retrospective Study of Immunotherapy Treatment with Uro-Vaxom (OM-89®) for Prophylaxis of Recurrent Urinary Tract Infections
Possibilities of Modern An- ti-Relapse Therapy of Urinary Tract Infections in Children: Crutil Trial 1 Year Follow-Up
![PDF) Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: A randomised controlled feasibility study PDF) Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: A randomised controlled feasibility study](https://i1.rgstatic.net/publication/332456457_Uro-VaxomR_versus_placebo_for_the_prevention_of_recurrent_symptomatic_urinary_tract_infections_in_participants_with_chronic_neurogenic_bladder_dysfunction_A_randomised_controlled_feasibility_study/links/5fc4dfda458515b7978a6168/largepreview.png)